Answer
Quviviq (daridorexant hydrochloride) should be used during pregnancy only if the woman's clinical condition requires daridorexant treatment, as there are no data in pregnant women, although animal studies did not indicate harmful effects on reproduction.
Sources for this answer
- QUVIVIQ 50 mg film-coated tabletsIdorsia Pharmaceuticals UK Ltd · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 5Document updated
Sources checked